{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:30:38Z","timestamp":1708043438350},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,15]]},"DOI":"10.7759\/cureus.54256","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T20:50:32Z","timestamp":1708030232000},"source":"Crossref","is-referenced-by-count":0,"title":["Should the Left Atrial Appendage Closure (LAAC) Technique Be the Main Form of Stroke Prevention in Patients With Long-Standing Persistent or Permanent Atrial Fibrillation?"],"prefix":"10.7759","author":[{"given":"Thebuoshon","family":"Amalathasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja A","family":"Nagaratnam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna","family":"El Dirani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius M","family":"Nagaratnam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Kholoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/heart.89.8.939","article-title":"Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment","volume":"89","author":"Markides V","year":"2003","unstructured":"Markides V, Schilling RJ. Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment. Heart. 2003, 89:939-43. 10.1136\/heart.89.8.939","journal-title":"Heart"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar JA","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al.. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024, 149:e1-e156. 10.1161\/CIR.0000000000001193","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2016.02.029","article-title":"Usefulness of CHADS2 and CHA2DS2-VASc scores in the prediction of new-onset atrial fibrillation: a population-based study","volume":"129","author":"Saliba W","year":"2016","unstructured":"Saliba W, Gronich N, Barnett-Griness O, Rennert G. Usefulness of CHADS2 and CHA2DS2-VASc scores in the prediction of new-onset atrial fibrillation: a population-based study. Am J Med. 2016, 129:843-9. 10.1016\/j.amjmed.2016.02.029","journal-title":"Am J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000250","article-title":"A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score","volume":"2","author":"Singer DE","year":"2013","unstructured":"Singer DE, Chang Y, Borowsky LH, et al.. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc. 2013, 2:e000250. 10.1161\/JAHA.113.000250","journal-title":"J Am Heart Assoc"},{"key":"ref5","article-title":"New oral anticoagulants for atrial fibrillation: are they worth the risk?","volume":"39","author":"Shafeeq H","year":"2014","unstructured":"Shafeeq H, Tran TH. New oral anticoagulants for atrial fibrillation: are they worth the risk?. P T. 2014, 39:54-64.","journal-title":"P T"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000015698.54752.6d","article-title":"Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience","volume":"105","author":"Sievert H","year":"2002","unstructured":"Sievert H, Lesh MD, Trepels T, et al.. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation. 2002, 105:1887-9. 10.1161\/01.cir.0000015698.54752.6d","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55090511","article-title":"Diagnosis and management of left atrium appendage thrombosis in atrial fibrillation patients undergoing cardioversion","volume":"55","author":"Melillo E","year":"2019","unstructured":"Melillo E, Palmiero G, Ferro A, Mocavero PE, Monda V, Ascione L. Diagnosis and management of left atrium appendage thrombosis in atrial fibrillation patients undergoing cardioversion. Medicina (Kaunas). 2019, 55:10.3390\/medicina55090511","journal-title":"Medicina (Kaunas)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034185","article-title":"Amplatzer amulet versus watchman device for percutaneous left atrial appendage closure: a systematic review and meta-analysis","volume":"102","author":"Jaiswal V","year":"2023","unstructured":"Jaiswal V, Ang SP, Shrestha AB, et al.. Amplatzer amulet versus watchman device for percutaneous left atrial appendage closure: a systematic review and meta-analysis. Medicine (Baltimore). 2023, 102:e34185. 10.1097\/MD.0000000000034185","journal-title":"Medicine (Baltimore)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-015-6632-3","article-title":"Stroke prevention in atrial fibrillation: a clinical perspective on trials of the novel oral anticoagulants","volume":"30","author":"Morais J","year":"2016","unstructured":"Morais J, De Caterina R. Stroke prevention in atrial fibrillation: a clinical perspective on trials of the novel oral anticoagulants. Cardiovasc Drugs Ther. 2016, 30:201-14. 10.1007\/s10557-015-6632-3","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24086879","article-title":"Challenges of anticoagulant therapy in atrial fibrillation-focus on gastrointestinal bleeding","volume":"24","author":"Scridon A","year":"2023","unstructured":"Scridon A, Balan AI. Challenges of anticoagulant therapy in atrial fibrillation-focus on gastrointestinal bleeding. Int J Mol Sci. 2023, 24:10.3390\/ijms24086879","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters R","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010, 138:1093-100. 10.1378\/chest.10-0134","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22435","article-title":"The HAS-BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: a systematic review and meta-analysis","volume":"38","author":"Zhu W","year":"2015","unstructured":"Zhu W, He W, Guo L, Wang X, Hong K. The HAS-BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: a systematic review and meta-analysis. Clin Cardiol. 2015, 38:555-61. 10.1002\/clc.22435","journal-title":"Clin Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.111.967000","article-title":"Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation","volume":"5","author":"Gallego P","year":"2012","unstructured":"Gallego P, Rold\u00e1n V, Torregrosa JM, et al.. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2012, 5:312-8. 10.1161\/CIRCEP.111.967000","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000176","article-title":"Aging and liver disease","volume":"31","author":"Kim IH","year":"2015","unstructured":"Kim IH, Kisseleva T, Brenner DA. Aging and liver disease. Curr Opin Gastroenterol. 2015, 31:184-91. 10.1097\/MOG.0000000000000176","journal-title":"Curr Opin Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2217\/cpr.14.46","article-title":"Chronic kidney disease in the elderly: evaluation and management","volume":"11","author":"Mallappallil M","year":"2014","unstructured":"Mallappallil M, Friedman EA, Delano BG, McFarlane SI, Salifu MO. Chronic kidney disease in the elderly: evaluation and management. Clin Pract (Lond). 2014, 11:525-35. 10.2217\/cpr.14.46","journal-title":"Clin Pract (Lond)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-17-00901","article-title":"Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices","volume":"13","author":"Weise FK","year":"2018","unstructured":"Weise FK, Bordignon S, Perrotta L, et al.. Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices. EuroIntervention. 2018, 13:e2138-46. 10.4244\/EIJ-D-17-00901","journal-title":"EuroIntervention"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960240313","article-title":"Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation","volume":"24","author":"Frick M","year":"2001","unstructured":"Frick M, Frykman V, Jensen-Urstad M, Ostergren J, Rosenqvist M. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. Clin Cardiol. 2001, 24:238-44. 10.1002\/clc.4960240313","journal-title":"Clin Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.004549","article-title":"Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis","volume":"2","author":"Ganesan AN","year":"2013","unstructured":"Ganesan AN, Shipp NJ, Brooks AG, et al.. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013, 2:e004549. 10.1161\/JAHA.112.004549","journal-title":"J Am Heart Assoc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208710","article-title":"Long term outcomes after left atrial appendage closure with the LARIAT device-stroke risk reduction over five years follow-up","volume":"13","author":"Litwinowicz R","year":"2018","unstructured":"Litwinowicz R, Bartus M, Burysz M, et al.. Long term outcomes after left atrial appendage closure with the LARIAT device-stroke risk reduction over five years follow-up. PLoS One. 2018, 13:e0208710. 10.1371\/journal.pone.0208710","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.084","article-title":"Time to cost-effectiveness following stroke reduction strategies in AF: warfarin versus NOACs versus LAA closure","volume":"66","author":"Reddy VY","year":"2015","unstructured":"Reddy VY, Akehurst RL, Armstrong SO, Amorosi SL, Beard SM, Holmes DR Jr. Time to cost-effectiveness following stroke reduction strategies in AF: warfarin versus NOACs versus LAA closure. J Am Coll Cardiol. 2015, 66:2728-39. 10.1016\/j.jacc.2015.09.084","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/226723-should-the-left-atrial-appendage-closure-laac-technique-be-the-main-form-of-stroke-prevention-in-patients-with-long-standing-persistent-or-permanent-atrial-fibrillation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T20:50:35Z","timestamp":1708030235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/226723-should-the-left-atrial-appendage-closure-laac-technique-be-the-main-form-of-stroke-prevention-in-patients-with-long-standing-persistent-or-permanent-atrial-fibrillation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.54256","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,15]]}}}